Skip to main content

Featured

Jordan Joins U.S.-Led Airstrikes Against ISIS in Syria

This photo provided by the U.S. Air Force shows a U.S. Airman preparing an A-10 Thunderbolt II for flight from a base in the U.S. Central Command area of responsibility, Friday, Dec. 19, 2025, in support of Operation Hawkeye Strike. Jordan announced that its air force has taken part in U.S.-led strikes targeting Islamic State positions in Syria, signaling a renewed show of regional cooperation against the extremist group. The operation comes as the United States carries out a series of retaliatory strikes following the recent killing of three American service members. In a statement, the Jordanian military said its aircraft conducted “precise airstrikes” on ISIS sites in southern Syria alongside U.S. forces. Officials emphasized that the mission aimed to prevent militant groups from using Syrian territory as a base to threaten neighboring countries. The U.S. strikes reportedly hit multiple ISIS-linked facilities, including infrastructure and weapons storage locations, as part of a b...

article

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Comments